Globe Life GL · NYSE
$168.74 +0.69% (+$1.15)
Summary
82 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 16% a year over the last 3 years.
- It has raised its dividend 10 years in a row and pays out only 8.0% of profit.
- Out of every 100 USD of revenue, 20 USD is left as net profit.
- The share price is below the Bulios Fair Price.
What to watch
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 10.6 USD for 1 USD of yearly profit. Over the last five years it was 10.7 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 4.8% a year over 5 years. Over the last 3 years it grew by 4.7% a year. Earnings per share grew by 16% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 83 USD
- Sales and administration 7.8 USD
- Taxes and other -10 USD
- Net profit 20 USD
Net profit, industry median (Insurance - Life) 10 USD
Out of every 100 USD of revenue, 20 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.75%
- Paid out of profit
- 8.0%
- Raised in a row
- 10 years
You receive $1.26 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 10
- Hold 11
- Sell 7
Today's price within the analysts' price targets
The average target of $187 is 11% above today's price. 36% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Life Segment 69%
- Health Segment 31%
By region
The company reports no revenue by region.
Life Segment brings in 69% of revenue. Health Segment grew fastest, by 6.2% a year.
Segments in detail